000 01734 a2200529 4500
005 20250516001929.0
264 0 _c20110120
008 201101s 0 0 eng d
022 _a1539-1612
024 7 _a10.1002/pst.458
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aIbia, Ekopimo
245 0 0 _aEthical considerations in industry-sponsored multiregional clinical trials.
_h[electronic resource]
260 _bPharmaceutical statistics
_c
300 _a230-41 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aBiomedical Research
_xethics
650 0 4 _aClinical Trials Data Monitoring Committees
650 0 4 _aConflict of Interest
650 0 4 _aDeveloping Countries
650 0 4 _aDrug Industry
_xethics
650 0 4 _aEthical Review
650 0 4 _aEthics Committees, Research
650 0 4 _aGeography
650 0 4 _aGovernment Regulation
650 0 4 _aGuidelines as Topic
650 0 4 _aHelsinki Declaration
650 0 4 _aHuman Experimentation
650 0 4 _aHumans
650 0 4 _aInformed Consent
_xethics
650 0 4 _aInternationality
650 0 4 _aMulticenter Studies as Topic
_xethics
650 0 4 _aRandomized Controlled Trials as Topic
_xethics
650 0 4 _aReproducibility of Results
650 0 4 _aResearch Design
650 0 4 _aSocial Justice
_xethics
700 1 _aBinkowitz, Bruce
700 1 _aSaillot, Jean-Louis
700 1 _aTalerico, Steven
700 1 _aKoerner, Chin
700 1 _aFerreira, Irene
700 1 _aAgarwal, Anupam
700 1 _aMetz, Craig
700 1 _aMaman, Marianne
773 0 _tPharmaceutical statistics
_gvol. 9
_gno. 3
_gp. 230-41
856 4 0 _uhttps://doi.org/10.1002/pst.458
_zAvailable from publisher's website
999 _c20157284
_d20157284